Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04454957 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mastering Diabetes Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 22, 2024 (before its estimated January 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jun 30, 2040 to Jun 30, 2025
    • Site details revised
    v6
  2. Primary completion date: Jan 1, 2024 to Jan 1, 2025v5
  3. Primary completion date: Jun 1, 2023 to Jan 1, 2024v4
  4. Primary completion date: Dec 31, 2021 to Jun 1, 2023
    • Eligibility criteria shortened, about 13 words
    • Study description shortened, about 46 words
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 21, 2020 to Aug 24, 2020
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Ohio University
10 trials monitored
See all monitored trials
Diabetes
5,087 trials monitored
See 222 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
This is a program evaluation that will evaluate the effectiveness of Mastering Diabetes, a therapeutic lifestyle change (TLC) program to control prediabetes and type 2 diabetes. Lifestyle change, focused on dietary change, physical activity, stress management and control of unhealthy substances has been demonstrated effective in preventing the progression of prediabetes, as well as reversal of diabetes and type 2 diabetes mellitus (T2DM).
Trial Details
NCT Number NCT04454957
Lead Sponsor Ohio University
Collaborators: Memorial Health System
Conditions
(from sponsor)		 Diabetes Mellitus, Type 2, PreDiabetes
Related terms Diabetes Mellitus, Diabetes Mellitus, Type 2, Motor Activity, Obesity, Overweight, Prediabetic State
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov